Target-treatment and patients' selection: can we still neglect the timing of tissue collection?

J Clin Oncol. 2005 Sep 1;23(25):6274-5; author reply 6275-6. doi: 10.1200/JCO.2005.01.9174.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Cetuximab
  • Colorectal Neoplasms / drug therapy
  • ErbB Receptors / biosynthesis
  • ErbB Receptors / classification*
  • Humans
  • Immunohistochemistry
  • Patient Selection*
  • Reproducibility of Results

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • ErbB Receptors
  • Cetuximab